You have full text access to this OnlineOpen article

A pilot phase-II prospective study to test the ‘efficacy’ and tolerability of a penile-extender device in the treatment of ‘short penis’

  1. Paolo Gontero,
  2. Massimiliano Di Marco,
  3. Gianluca Giubilei,
  4. Riccardo Bartoletti,
  5. Giovanni Pappagallo,
  6. Alessandro Tizzani,
  7. Nicola Mondaini

Article first published online: 17 OCT 2008

DOI: 10.1111/j.1464-410X.2008.08083.x

Issue

BJU International

BJU International

Volume 103, Issue 6, pages 793–797, March 2009

Additional Information

How to Cite

Gontero, P., Di Marco, M., Giubilei, G., Bartoletti, R., Pappagallo, G., Tizzani, A. and Mondaini, N. (2009), A pilot phase-II prospective study to test the ‘efficacy’ and tolerability of a penile-extender device in the treatment of ‘short penis’. BJU International, 103: 793–797. doi: 10.1111/j.1464-410X.2008.08083.x

Author Information

  1. Dipartimento di Discipline Medico Chirurgiche, Urologia 1, San Giovanni Battista Hospital, University of Turin, Turin, Italy

*Paolo Gontero, Senior Lecturer and Consultant Urologist, Dipartimento di Discipline Medico Chirurgiche, University of Turin, Urologia 1, San Giovanni Battista Hospital, C.so Dogliotti, 14, Torino, Italy. e-mail: paolo.gontero@unito.it

Publication History

  1. Issue published online: 23 FEB 2009
  2. Article first published online: 17 OCT 2008
  3. Accepted for publication 9 July 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (138K)

Keywords:

  • penile extender;
  • penile dysmorphophobia;
  • penile size;
  • short penis

OBJECTIVE

To assess a commonly marketed brand of penile extender, the Andro-Penis® (Andromedical, Madrid, Spain), widely used devices which aim to increase penile size, in a phase II single-arm study powered to detect significant changes in penile size, as despite their widespread use, there is little scientific evidence to support their potential clinical utility in the treatment of patients with inadequate penile dimensions.

PATIENTS AND METHODS

Fifteen patients were required to test the efficacy of the device, assuming an effect size of >0.8. Eligible patients were counselled how to use the penile extender for at least 4 h/day for 6 months. Penile dimensions were measured at baseline and after 1, 3, 6 and 12 months (end of study). The erectile function (EF) domain of the International Index of EF was administered at baseline and at the end of the study. Treatment satisfaction was assessed using an institutional unvalidated five-item questionnaire.

RESULTS

After 6 months the mean gain in length was significant, meeting the goals of the effect size, at 2.3 and 1.7 cm for the flaccid and stretched penis, respectively. No significant changes in penile girth were detected. The EF domain scores improved significantly at the end of study. Treatment satisfaction scores were consistent with acceptable to good improvement in all items, except for penile girth, where the score was either ‘no change’ or ‘mild improvement’.

CONCLUSIONS

Penile extenders should be regarded as a minimally invasive and effective treatment option to elongate the penile shaft in patients seeking treatment for a short penis.

View Full Article (HTML) Get PDF (138K)